文献速递肝病消化道肿瘤与早癌

TAZ诱导的Cybb基因促进非酒精性脂肪性肝炎肝肿瘤形成

TAZ-induced Cybb contributes to liver tumor formation in non-alcoholic steatohepatitis.
PubMed 文献 · J Hepatol · 2021-12-11

本研究探讨TAZ/WWTR1在非酒精性脂肪性肝炎(NASH)向肝细胞癌(HCC)进展中的作用,利用饮食诱导和遗传性NASH-HCC小鼠模型进行基因靶向、AAV8介导的基因沉默或表达,并在人NASH-HCC肝标本中验证。结果显示,沉默肝细胞TAZ可抑制肿瘤发生,其机制涉及TAZ诱导Cybb表达导致NADPH介导的氧化DNA损伤;作者认为靶向TAZ的NASH治疗可能预防NASH-HCC。

要点

  • 在癌前NASH小鼠中沉默肝细胞TAZ可抑制后续HCC肿瘤发展。
  • TAZ通过诱导Cybb表达导致NADPH介导的氧化DNA损伤。
  • 人NASH-HCC非肿瘤组织中TAZ、NOX2与氧化DNA损伤强相关。

核心结论

  • 癌前NASH肝细胞中的TAZ通过诱导Cybb和NOX2介导的DNA损伤促进后续HCC肿瘤发展。
  • 作者认为靶向TAZ的NASH治疗可能同时预防NASH-HCC。

研究设计与样本

  • 研究使用饮食诱导和遗传性NASH-HCC小鼠模型,采用基因靶向、AAV8-H1介导的基因沉默或AAV8-TBG介导的基因表达。
  • 研究在人NASH-HCC肝标本中检测新通路的生化特征。

主要发现

  • 在癌前NASH小鼠中使用AAV8-H1-shTaz沉默肝细胞TAZ后,后续HCC肿瘤发展被抑制。
  • shTaz的抑瘤效应不依赖于肿瘤自身的TAZ沉默,且可与shTaz的NASH抑制效应分离。
  • TAZ介导诱导NOX2编码基因Cybb,导致NADPH介导的氧化DNA损伤。
  • 用AAV8-H1-shCybb、AAV8-TBG-OGG1或AAV8-TBG-NHEJ1处理癌前NASH小鼠可抑制DNA损伤和肿瘤形成。
  • 人NASH-HCC肝非肿瘤组织中TAZ、NOX2与氧化DNA损伤呈强相关。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND & AIMS: Non-alcoholic steatohepatitis (NASH) is a leading cause of hepatocellular carcinoma (HCC), but mechanisms linking NASH to eventual tumor formation remain poorly understood. Herein, we investigate the role of TAZ/WWTR1, which is induced in hepatocytes in NASH, in the progression of NASH to HCC. METHODS: The roles of hepatocyte TAZ and its downstream targets were investigated in diet-induced and genetic models of NASH-HCC using gene-targeting, adeno-associated virus 8 (AAV8)-H1-mediated gene silencing, or AAV8-TBG-mediated gene expression. The biochemical signature of the newly elucidated pathway was probed in liver specimens from humans with NASH-HCC. RESULTS: When hepatocyte-TAZ was silenced in mice with pre-tumor NASH using AAV8-H1-shTaz (short-hairpin Taz), subsequent HCC tumor development was suppressed. In this setting, the tumor-suppressing effect of shTaz was not dependent of TAZ silencing in the tumors themselves and could be dissociated from the NASH-suppressing effects of shTaz. The mechanism linking pre-tumor hepatocyte-TAZ to eventual tumor formation involved TAZ-mediated induction of the NOX2-encoding gene Cybb, which led to NADPH-mediated oxidative DNA damage. As evidence, DNA damage and tumor formation could be suppressed by treatment of pre-tumor NASH mice with AAV8-H1-shCybb; AAV8-TBG-OGG1, encoding the oxidative DNA-repair enzyme 8-oxoguanine glycosylase; or AAV8-TBG-NHEJ1, encoding the dsDNA repair enzyme non-homologous end-joining factor 1. In surrounding non-tumor tissue from human NASH-HCC livers, there were strong correlations between TAZ, NOX2, and oxidative DNA damage. CONCLUSIONS: TAZ in pre-tumor NASH-hepatocytes, via induction of Cybb and NOX2-mediated DNA damage, contributes to subsequent HCC tumor development. These findings illustrate how NASH provides a unique window into the early molecular events that can lead to tumor formation and suggest that NASH therapies targeting TAZ might also prevent NASH-HCC. LAY SUMMARY: Non-alcoholic steatohepatitis (NASH) is emerging as the leading cause of a type of liver cancer called hepatocellular carcinoma (HCC), but molecular events in pre-tumor NASH hepatocytes leading to HCC remain largely unknown. Our study shows that a protein called TAZ in pre-tumor NASH-hepatocytes promotes damage to the DNA of hepatocytes and thereby contributes to eventual HCC. This study reveals a very early event in HCC that is induced in pre-tumor NASH, and the findings suggest that NASH therapies targeting TAZ might also prevent NASH-HCC.

来源:J Hepatol,查看原文。版权归原作者所有。

引用

  1. Wang X, Zeldin S, Shi H, et al. TAZ-induced Cybb contributes to liver tumor formation in non-alcoholic steatohepatitis. J Hepatol. 2021. PMID: 34902531. doi:10.1016/j.jhep.2021.11.031

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。